• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[对一名骨髓性白血病患者间歇性给予天然α干扰素超过5年诱导费城染色体完全抑制]

[Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].

作者信息

Koyama S, Aoki S, Furukawa T, Takahashi M, Kishi K, Koike T, Moriyama Y, Hattori A, Shibata A

机构信息

Department of Hematology and Oncology, Saiseikai Niigata Second Hospital.

出版信息

Rinsho Ketsueki. 1991 Dec;32(12):1577-9.

PMID:1779460
Abstract

A 60-year-old woman was admitted to our hospital because of gastric ulcer, anemia, and leukocytosis in November 1984. Blood cell counts on admission were as follows: RBC 407 x 10(4)/microliters, Hb 9.8 g/dl, WBC 33,000/microliters (baso 8%, eo 7%, myelo 11%, meta 2%, stab 4%, seg 54%), Plt 93.7 x 10(4)/microliters. Bone marrow showed hypercellular and myeloid hyperplasia. She was diagnosed as Ph1-chromosome positive chronic myelogenous leukemia. She received natural interferon-alpha at the dosage of 600 x 10(4) IU daily for 22 days from January 14, 1985. After March 1985, she has been given intermittent administration of interferon once in 10 to 20 days, and maintained normal blood cell counts. Cytogenetic improvement was seen on 35 months after the start of IFN and complete suppression of Ph1 chromosome was observed at July 1990 (66 months after).

摘要

一名60岁女性因胃溃疡、贫血和白细胞增多于1984年11月入院。入院时血细胞计数如下:红细胞407×10⁴/微升,血红蛋白9.8克/分升,白细胞33000/微升(嗜碱性粒细胞8%,嗜酸性粒细胞7%,中幼粒细胞11%,晚幼粒细胞2%,杆状核粒细胞4%,分叶核粒细胞54%),血小板93.7×10⁴/微升。骨髓显示细胞增多和髓系增生。她被诊断为Ph1染色体阳性慢性粒细胞白血病。1985年1月14日起,她接受了每日600×10⁴国际单位的天然α干扰素治疗,共22天。1985年3月后,她每10至20天接受一次干扰素间歇给药,并维持血细胞计数正常。干扰素开始使用35个月后出现细胞遗传学改善,1990年7月(66个月后)观察到Ph1染色体完全抑制。

相似文献

1
[Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].[对一名骨髓性白血病患者间歇性给予天然α干扰素超过5年诱导费城染色体完全抑制]
Rinsho Ketsueki. 1991 Dec;32(12):1577-9.
2
[Natural interferon-alpha induced cytogenetic complete remission in a patient with chronic myelocytic leukemia, diagnosed in early chronic phase with basophilia and normal blood cell counts].
Rinsho Ketsueki. 1992 Feb;33(2):227-31.
3
[One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Rinsho Ketsueki. 1990 Jul;31(7):1013-6.
4
[Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].[慢性粒细胞白血病伴髓系-巨核细胞系危象患者对低剂量天然α干扰素的血液学反应]
Rinsho Ketsueki. 1993 Feb;34(2):232-4.
5
[Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].[慢性粒细胞白血病的初始治疗——干扰素还是骨髓移植]
Gan To Kagaku Ryoho. 1999 Sep;26(10):1381-6.
6
[Molecular implication of Ph positive leukemias: treatment with alpha-interferon in Ph positive acute leukemia].[Ph阳性白血病的分子机制:α干扰素治疗Ph阳性急性白血病]
Rinsho Byori. 1993 Dec;41(12):1305-9.
7
[Disappearance of Philadelphia chromosomes after remission induction in lymphoid crisis of chronic myelogenous leukemia].[慢性粒细胞白血病淋巴危象缓解诱导后费城染色体消失]
Rinsho Ketsueki. 1992 Sep;33(9):1226-30.
8
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.慢性粒细胞白血病患者接受高剂量化疗放疗后进行自体费城染色体阴性血液祖细胞移植。
Bone Marrow Transplant. 1996 Feb;17(2):201-5.
9
Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.甲磺酸伊马替尼治疗可改善新诊断的慢性期费城染色体阳性慢性髓性白血病患者的生存率:与历史数据比较。
Cancer. 2003 Dec 15;98(12):2636-42. doi: 10.1002/cncr.11831.
10
[Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
Rinsho Ketsueki. 2001 Jul;42(7):549-53.